Search research articles

Search research articles

Related Experiment Videos

Multi-peptide coupled-cell tolerance ameliorates ongoing relapsing EAE associated with multiple pathogenic

Cassandra E Smith¹, Stephen D Miller

¹Department of Microbiology and Immunology, Feinberg School of Medicine, Northwestern University, Tarry 6-718, 303 E. Chicago Ave, Chicago, IL 60611, USA.

Journal of Autoimmunity

|February 10, 2007

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Regulatory B cells contribute to allergen-encapsulating nanoparticle immunotherapy efficacy for food allergy.

JCI insight·2026

Same author

Myeloid Cell-Targeting PLGA Nanoparticles Ameliorate Acute Graft-Versus-Host Disease.

Cancers·2026

Same author

Antigen-specific immunotherapy with a CD4<sup>+</sup> T cell neoepitope restrains CD8<sup>+</sup> T cell differentiation in murine pancreatic islet grafts.

Nature communications·2026

Same author

Losartan Alleviates Chemical Burn-Induced Limbal Stem Cell Deficiency: Repurposing a Venerable Anti-Hypertension Drug.

Investigative ophthalmology & visual science·2026

Same author

STING/type I interferon pathway is required for antigen-containing PLGA nanoparticle- and apoptotic cell-induced CD4+ T cell tolerance.

Science advances·2026

Same author

Wnt-Activated Immunoregulatory Myeloid Cells Prevent Relapse in Experimental Autoimmune Encephalomyelitis and Offer a Potential Therapeutic Strategy for Multiple Sclerosis.

bioRxiv : the preprint server for biology·2025

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Targeting multiple myelin epitopes simultaneously with peptide cocktails can induce tolerance in mice, preventing and treating experimental autoimmune encephalomyelitis (EAE). This approach offers a promising strategy for multiple sclerosis (MS) therapy.

Area of Science:

Immunology
Neuroimmunology
Autoimmune Diseases

Background:

Multiple sclerosis (MS) involves immune responses to multiple myelin epitopes.
Current peptide-specific tolerance therapies targeting single epitopes are limited by epitope spreading in MS.
Developing therapies that target multiple autoepitopes simultaneously is crucial for effective MS treatment.

Purpose of the Study:

To investigate the efficacy of peptide cocktails in inducing simultaneous T cell tolerance to multiple autoepitopes.
To determine if this approach can prevent and treat experimental autoimmune encephalomyelitis (EAE) in a mouse model.

Main Methods:

Utilized a novel ECDI coupled-APC tolerance system with peptide cocktails in mice.
Administered peptide cocktails containing four distinct encephalitogenic epitopes (PLP, MBP, MOG) for preventative and therapeutic tolerance induction.

Related Experiment Videos

Assessed T cell activation, inflammatory cell infiltration in the CNS, and clinical EAE scores.

Main Results:

Preventative tolerance induction inhibited EAE initiation induced by individual peptides or a mixture.
Therapeutic tolerance, administered at peak disease, prevented relapses and ameliorated EAE caused by epitope spreading.
Therapeutic tolerance increased anti-inflammatory cytokines (TGF-beta, IL-10) in periphery and CNS, suggesting a distinct mechanism from preventative tolerance.

Conclusions:

Peptide cocktail tolerance induction is effective in preventing and treating EAE in mice, addressing limitations of single-epitope therapies.
This strategy holds potential for managing MS by simultaneously targeting multiple autoantigens and mitigating epitope spreading.
Therapeutic tolerance mediated by cytokine induction offers a novel mechanism for treating established autoimmune disease.